Skip to main content
OpenTrials
Completed

NCT Number: NCT00670670

A Prospective, Randomized Clinical Study on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 1

Influence of CPP-ACP paste on the evolution and appearance of white spot lesions in orthodontic patients after removal of the fixed appliances.

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Ghent

Ghent, 9000, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • one or more white spot lesion at the time of removal of fixed appliances

Exclusion criteria

  • white spots already present before start orthodontic treatment

Treatment and study plan

CPP-ACP (GC Tooth Mousse)

Device

Calcium and phosphate

CPP-ACP (GC MI Paste Plus)

Device

Calcium, phosphate and fluoride

Primary outcomes

  1. Amelioration of the opacity of white spots into a more natural tooth-like translucency

    Time frame: After 6 months

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Collaborators

  • GC Europe

Registry information

Official study title

A Prospective, Randomized Clinical Study on the Effects of CPP-ACP Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 1

Important dates

Study start
2008
Primary completion
2011
Study completion
2011
First posted
May 2, 2008
Registry last updated
May 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.